The child or adolescent with elevated blood pressure

New England Journal of Medicine

Volumn 370, Issue 24, 2014, Pages 2316-2325

  Ingelfinger, Julie R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; CHLORTALIDONE; CLONIDINE; ENALAPRIL; EPLERENONE; FUROSEMIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; ISRADIPINE; LABETALOL; LISINOPRIL; LOSARTAN; METOPROLOL; MINOXIDIL; NIFEDIPINE; PROPRANOLOL; SPIRONOLACTONE; VALSARTAN; ANTIHYPERTENSIVE AGENT;

ADOLESCENT; ARTICLE; BLOOD PRESSURE MONITORING; CHILD; CLINICAL EFFECTIVENESS; DAIRY PRODUCT; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELEVATED BLOOD PRESSURE; FRUIT; HUMAN; LIFESTYLE MODIFICATION; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VEGETABLE; WEIGHT REDUCTION; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; FEMALE; HYPERTENSION; MALE; OBESITY; PHYSIOLOGY; REFERENCE VALUE; REVIEW;

ADOLESCENT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CHILD; FEMALE; HUMANS; HYPERTENSION; MALE; OBESITY; REFERENCE VALUES; WEIGHT LOSS;

EID: 84902149353     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1001120     Document Type: Article

References (55)

1. Lo JC, Sinaiko A, Chandra M, et al. Prehypertension and hypertension in community-based pediatric practice. Pediatrics 2013;131(2):e415-e424.
2. Flynn JT. The changing face of pediatric hypertension in the era of the childhood obesity epidemic. Pediatr Nephrol 2013;28:1059-66.
3. Chockalingam A, Campbell NR, Fodor JG. Worldwide epidemic of hypertension. Can J Cardiol 2006;22:553-5.
4. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:Suppl:555-76.
5. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72. [Erratum, JAMA 2003; 290:197.]
6. James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20.
7. Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens 1995;8:657-65.
8. Lauer RM, Clarke WR. Childhood risk factors for high adult blood pressure: the Muscatine Study. Pediatrics 1989;84:633-41.
9. Carrico RJ, Sun SS, Sima AP, Rosner B. The predictive value of childhood blood pressure values for adult elevated blood pressure. Open J Pediatr 2013;3:116-26.
10. Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation 2008;117:3171-80.
11. Kaelber DC, Pickett F. Simple table to identify children and adolescents needing further evaluation of blood pressure. Pediatrics 2009;123(6):e972-e974.
12. McLaughlin D, Hayes JR, Kelleher K. Office-based interventions for recognizing abnormal pediatric blood pressures. Clin Pediatr (Phila) 2010;49:355-62.
13. Mitchell CK, Theriot JA, Sayat JG, Muchant DG, Franco SM. A simplified table improves the recognition of paediatric hypertension. J Paediatr Child Health 2011;47:22-6.
14. Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA 2007;298: 874-9.
15. Brady TM, Fivush B, Flynn JT, Parekh R. Ability of blood pressure to predict left ventricular hypertrophy in children with primary hypertension. J Pediatr 2008;152: 73-8.
16. McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 2007; 150:640-4.
17. Ramos E, Barros H. Prevalence of hypertension in 13-year-old adolescents in Porto, Portugal. Rev Port Cardiol 2005; 24:1075-87.
18. Salvadori M, Sontrop JM, Garg AX, et al. Elevated blood pressure in relation to overweight and obesity among children in a rural Canadian community. Pediatrics 2008;122(4):e821-e827.
19. Feber J, Ahmed M. Hypertension in children: new trends and challenges. Clin Sci (Lond) 2010;119:151-61.
20. Thompson M, Dana T, Bougatsos C, Blazina I, Norris SL. Screening for hypertension in children and adolescents to prevent cardiovascular disease. Pediatrics 2013;131:490-525.
21. Moyer VA. Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Pediatrics 2013;132: 907-14.
22. McNiece KL, Gupta-Malhotra M, Samuels J, et al. Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension 2007;50:392-5.
23. Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 2010;362:485-93.
24. Bibbins-Domingo K, Pletcher MJ, Lin F, et al. Racial differences in incident heart failure among young adults. N Engl J Med 2009;360:1179-90.
25. Erlingsdottir A, Indridason OS, Thorvaldsson O, Edvardsson VO. Blood pressure in children and target-organ damage later in life. Pediatr Nephrol 2010;25:323-8.
26. Li S, Chen W, Srinivasan SR, Berenson GS. Childhood blood pressure as a predictor of arterial stiffness in young adults: the Bogalusa Heart Study. Hypertension 2004;43:541-6.
27. Flynn JT, Alderman MH. Characteristics of children with primary hypertension seen at a referral center. Pediatr Nephrol 2005;20:961-6.
28. Butani L, Morgenstern BZ. Are pitfalls of oxcillometric blood pressure measurements preventable in children? Pediatr Nephrol 2003;18:313-8.
29. Flynn JT, Urbina EM. Pediatric ambulatory blood pressure monitoring: indications and interpretations. J Clin Hypertens (Greenwich) 2012;14:372-82.
30. Hammerness PG, Perrin JM, Shelley-Abrahamson R, Wilens TE. Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations. J Am Acad Child Adolesc Psychiatry 2011;50: 978-90.
31. Gidding SS, Daniels SR, Kavey RE. Developing the 2011 Integrated Pediatric Guidelines for Cardiovascular Risk Reduction. Pediatrics 2012;129(5):e1311-e1319.
32. Urbina E, Alpert B, Flynn J, et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young and the Council for High Blood Pressure Research. Hypertension 2008;52: 433-51.
33. Stabouli S, Kotsis V, Rizos Z, et al. Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents. Pediatr Nephrol 2009;24: 1545-51.
34. Mitchell P, Cheung N, de Haseth K, et al. Blood pressure and retinal arteriolar narrowing in children. Hypertension 2007; 49:1156-62.
35. Adams HR, Szilagyi PG, Gebhardt L, Lande MB. Learning and attention problems among children with pediatric primary hypertension. Pediatrics 2010;126(6): e1425-e1429.
36. Lande MB, Adams HR, Kupferman JC, Hooper SR, Szilagyi PG, Batisky DL. A multicenter study of neurocognition in children with hypertension: methods, challenges, and solutions. J Am Soc Hypertens 2013;7:353-62.
37. Sorof JM, Alexandrov AV, Garami Z, et al. Carotid ultrasonography for detection of vascular abnormalities in hypertensive children. Pediatr Nephrol 2003;18:1020-4.
38. Holm JC, Gamborg M, Neland M, et al. Longitudinal changes in blood pressure during weight loss and regain of weight in obese boys and girls. J Hypertens 2012;30:368-74.
39. Kalarchian MA, Levine MD, Arslanian SA, et al. Family-based treatment of severe pediatric obesity: randomized, controlled trial. Pediatrics 2009;124:1060-8.
40. Appel LJ, Giles TD, Black HR, et al. ASH Position Paper: dietary approaches to lower blood pressure. J Clin Hypertens (Greenwich) 2009;11:358-68.
41. Günther AL, Liese AD, Bell RA, et al. Association between the dietary approaches to hypertension diet and hypertension in youth with diabetes mellitus. Hypertension 2009;53:6-12.
42. Couch SC, Saelens BE, Levin L, Dart K, Falciglia G, Daniels SR. The efficacy of a clinic-based behavioral nutrition intervention emphasizing a DASH-type diet for adolescents with elevated blood pressure. J Pediatr 2008;152:494-501.
43. Shalitin S, Ashkenazi-Hoffnung L, Yackobovitch-Gavan M, et al. Effects of a twelve-week randomized intervention of exercise and/or diet on weight loss and weight maintenance, and other metabolic parameters in obese preadolescent children. Horm Res 2009;72:287-301.
44. Fixler DE, Laird WP, Dana K. Usefulness of exercise stress testing for prediction of blood pressure trends. Pediatrics 1985;75:1071-5.
45. Schofield G, Schofield L, Hinckson EA, Mummery WK. Daily step counts and selected coronary heart disease risk factors in adolescent girls. J Sci Med Sport 2009;12:148-55.
46. Stabouli S, Papakatsika S, Kotsis V. The role of obesity, salt and exercise on blood pressure in children and adolescents. Expert Rev Cardiovasc Ther 2011;9: 753-61.
47. McCambridge TM, Benjamin HJ, Brenner JS, et al. Athletic participation by children and adolescents who have systemic hypertension. Pediatrics 2010;125: 1287-94.
48. Flynn JT, Daniels SR. Pharmacologic treatment of hypertension in children and adolescents. J Pediatr 2006;149:746-54.
49. Robinson RF, Nahata MC, Batisky DL, Mahan JD. Pharmacologic treatment of chronic pediatric hypertension. Paediatr Drugs 2005;7:27-40.
50. Ferguson MA, Flynn JT. Pharmacologic treatment of childhood hypertension. In: Flynn JT, Ingelfinger JR, Portman RJ, eds. Pediatric hypertension. 3rd ed. New York: Springer, 2013:539-55.
51. Litwin M, Niemirska A, Sladowska-Kozlowska J, et al. Regression of target organ damage in children and adolescents with primary hypertension. Pediatr Nephrol 2010;25:2489-99.
52. Seeman T, Gilík J, Vondrák K, et al. Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy. Am J Hypertens 2007;20:990-6.
53. Woroniecki RP, Flynn JT. How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists. Pediatr Nephrol 2005; 20:791-7.
54. Lurbe E, Cifkova R, Cruickshank JK, et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009;27:1719-42.
55. Daniels SR, Gidding SS. Blood pressure screening in children and adolescents: is the glass half empty or more than half full? JAMA Pediatr 2013;167:302-4.